By Collins Mutua, Head of Biostatistics, DNDi
Have you ever wondered how the pills in your medicine cabinet actually make it to you?
It takes a village to develop new medicines. The village comprises researchers, clinicians, clinical trial participants, regulatory authorities, and distributors. Drug companies undergo a rigorous process of experimentation to discover new drugs and assess drugs’ safety in labs before conducting clinical trials in humans. Once safety and efficacy are determined in clinical trials, regulatory agencies review the findings and approve new drugs for production and marketing. Drugs then undergo post-marketing monitoring to ensure their continued safety and efficacy.